N-(2-chlorophenyl)-6-phenylimidazo[1,2-a]pyridine-3-carboxamide

ID: ALA1078739

PubChem CID: 46882707

Max Phase: Preclinical

Molecular Formula: C20H14ClN3O

Molecular Weight: 347.81

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccccc1Cl)c1cnc2ccc(-c3ccccc3)cn12

Standard InChI:  InChI=1S/C20H14ClN3O/c21-16-8-4-5-9-17(16)23-20(25)18-12-22-19-11-10-15(13-24(18)19)14-6-2-1-3-7-14/h1-13H,(H,23,25)

Standard InChI Key:  HEAMMOPNKRHYGX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    1.9152  -20.7041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9141  -21.5315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6289  -21.9444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6271  -20.2914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3425  -20.7005    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3473  -21.5269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1348  -21.7778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6167  -21.1063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1270  -20.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1440  -19.6175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8659  -19.2181    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4372  -19.1921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4522  -18.3672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1786  -17.9712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1940  -17.1471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4888  -16.7280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7623  -17.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7505  -17.9474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0299  -18.3492    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.2028  -20.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2039  -19.4659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4902  -19.0536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2252  -19.4663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2223  -20.2956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4920  -20.7041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10 12  1  0
  2  3  2  0
 12 13  1  0
  3  6  1  0
 13 14  2  0
  1  2  1  0
 14 15  1  0
  5  4  1  0
 15 16  2  0
  6  7  2  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
 18 13  1  0
  8  9  2  0
 18 19  1  0
  9  5  1  0
  4  1  2  0
 20 21  2  0
  9 10  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 10 11  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  1 20  1  0
M  END

Associated Targets(Human)

EPHB3 Tchem Ephrin type-B receptor 3 (1881 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.81Molecular Weight (Monoisotopic): 347.0825AlogP: 4.91#Rotatable Bonds: 3
Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.39CX LogP: 4.02CX LogD: 4.02
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.57Np Likeness Score: -1.66

References

1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD..  (2009)  Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors.,  19  (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010]

Source